Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Provided By GlobeNewswire
Last update: Aug 1, 2025
CHARLESTOWN, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 55,450 restricted stock units (“RSUs”) to four newly hired employees.
Read more at globenewswire.com
